Development of a Pilot Scale Process for the Anti-Alzheimer Drug (−)-Galanthamine Using Large-Scale Phenolic Oxidative Coupling and Crystallisation-Induced Chiral Conversion
- 1 November 1999
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 3 (6) , 425-431
- https://doi.org/10.1021/op990019q
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- New kilogram-synthesis of the anti-alzheimer drug (−)-galanthamineTetrahedron Letters, 1998
- A concise, scaleable synthesis of narwedineTetrahedron Letters, 1997
- Clinical studies with galanthamineDrugs of Today, 1997
- Asymmetric Transformation of Either Enantiomer of Narwedine via Total Spontaneous Resolution Process, a Concise Solution to the Synthesis of (-)-GalanthamineThe Journal of Organic Chemistry, 1994
- Narcissus nivalis: A New Source of Galanthamine1Planta Medica, 1990
- Selective demethylation of 3,4-dimethoxy-substituted aromatic aldehydes and ketonesThe Journal of Organic Chemistry, 1967
- Clinical Experiences with Diallyl-Nor-Toxiferine and the Curare Antidote GalanthamineSouthern Medical Journal, 1966
- 153. Phenol oxidation and biosynthesis. Part V. The synthesis of galanthamineJournal of the Chemical Society, 1962
- Zur Konstitution der Phenolaldehyd‐Salze. (II.)European Journal of Inorganic Chemistry, 1915
- Über die Bromierung von m‐Oxybenzaldehyd, Vanillin und HomovanillinsäureEuropean Journal of Organic Chemistry, 1912